Bionano to Present at the Canaccord Genuity 44th Annual Growth Conference

Rhea-AI Summary

Bionano Genomics (Nasdaq: BNGO) has announced that its CEO, Erik Holmlin, will be presenting at the Canaccord Genuity 44th Annual Growth Conference on August 13, 2024. The presentation is scheduled for 3:30 p.m. to 3:55 p.m. ET.

Interested parties can register for the webcast through a provided link. For those unable to attend live, a replay of the session will be available on the Bionano website at https://ir.bionano.com/ for at least 30 days following the conference.

This presentation offers an opportunity for investors and analysts to gain insights into Bionano's growth strategies and recent developments in the genomics field.

News Market Reaction – BNGO

-8.45%

-8.45% Session move

In the trading session that priced this news, BNGO declined 8.45%, reflecting a notable negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SAN DIEGO, July 31, 2024 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that Erik Holmlin, PhD, Bionano’s president and chief executive officer, will present at the Canaccord Genuity 44^th Annual Growth Conference on August 13, 2024.

Conference & Webcast Details

Date:	August 13, 2024
Time:	3:30 p.m. to 3:55 p.m. ET
Presenter:	Erik Holmlin, PhD, CEO of Bionano
Webcast:	Link to Register

A replay / recording of the session will be available following the conference through the Bionano website at https://ir.bionano.com/ for at least 30 days.

About Bionano

Bionano is a provider of genome analysis solutions that can enable researchers and clinicians to reveal answers to challenging questions in biology and medicine. The Company’s mission is to transform the way the world sees the genome through OGM solutions, diagnostic services and software. The Company offers OGM solutions for applications across basic, translational and clinical research. The Company also offers an industry-leading, platform-agnostic genome analysis software solution and nucleic acid extraction and purification solutions using proprietary isotachophoresis (ITP) technology. Through its Lineagen, Inc. d/b/a Bionano Laboratories business, the Company also offers OGM-based diagnostic testing services.

For more information, visit http://www.bionano.com or www.bionanolaboratories.com. 

Bionano’s OGM products are for research use only and not for use in diagnostic procedures.

CONTACTS

Company Contact:
Erik Holmlin, CEO
Bionano Genomics, Inc.
+1 (858) 888-7610
eholmlin@bionano.com 

Investor Relations:
David Holmes
Gilmartin Group
+1 (858) 888-7625
IR@bionano.com 

FAQ

When is Bionano Genomics (BNGO) presenting at the Canaccord Genuity Growth Conference?

Bionano Genomics (BNGO) is presenting at the Canaccord Genuity 44th Annual Growth Conference on August 13, 2024, from 3:30 p.m. to 3:55 p.m. ET.

Who will be presenting for Bionano Genomics (BNGO) at the Canaccord Genuity conference?

Erik Holmlin, PhD, the president and chief executive officer of Bionano Genomics, will be presenting at the Canaccord Genuity conference.

How can I watch Bionano Genomics' (BNGO) presentation at the Canaccord Genuity conference?

You can register for the webcast through a link provided by Bionano Genomics. A replay of the session will also be available on the Bionano website at https://ir.bionano.com/ for at least 30 days after the conference.

What is the significance of Bionano Genomics (BNGO) presenting at the Canaccord Genuity conference?

Presenting at the Canaccord Genuity Growth Conference provides Bionano Genomics an opportunity to showcase their growth strategies and recent developments to investors and analysts in the genomics field.